Frequent Self-Monitoring Blood Glucose Correlated to Better Medication Adherence and Glycemic Control in Children

Nur Rochmah1,2, Soetjipto Soetjipto3, Muhammad Faizi1,2

  • 1Department of Child Health, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

Insights

Higher frequency of self-monitoring of blood glucose (SMBG) in children with type 1 diabetes is linked to better glycemic control and medication adherence. However, less than 50% of Indonesian children meet recommended SMBG guidelines.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Management
  • Public Health

Background:

  • Type 1 diabetes mellitus (T1DM) is a prevalent chronic childhood condition with significant complications.
  • Effective diabetes management hinges on glycemic control, primarily influenced by self-monitoring of blood glucose (SMBG) compliance.
  • In Indonesia, traditional finger-stick devices are common, yet only about 20% of children adhere to recommended SMBG frequencies (4-6 times daily).

Purpose of the Study:

  • To investigate the relationship between SMBG adherence and glycemic control in Indonesian children with T1DM.
  • To assess psychosocial conditions and medication adherence in pediatric T1DM patients.
  • To provide insights into improving diabetes management strategies within the Indonesian context.

Main Methods:

  • A single-center, cross-sectional study involving 36 children (aged 4-18) with T1DM at Dr. Soetomo Hospital, Surabaya, Indonesia (July-November 2022).
  • SMBG compliance was assessed via questionnaire.
  • Psychosocial factors and medication adherence were evaluated using the Pediatric Symptom Checklist 17 and ARMS-D, respectively. Statistical analyses included Pearson correlation and linear regression.

Main Results:

  • SMBG frequency exceeding 4 times daily significantly correlated with increased medication adherence (p=0.012).
  • Higher SMBG frequency was associated with lower HbA1c levels (p=0.014, r=0.406) and improved nutritional status (p=0.031, r=0.360).
  • Less than 50% of Indonesian pediatric T1DM patients met the recommended SMBG guideline of at least 4 times per day.

Conclusions:

  • Increased SMBG frequency is linked to better glycemic control and adherence in children with T1DM.
  • There is a critical need for enhanced support to promote adherence to national SMBG guidelines among pediatric patients in Indonesia.
  • Future research should consider larger sample sizes and multi-center collaborations to validate these findings.
Abstract

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
260
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
166
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
523
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
256